Loading data
CVEONYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 638.85 m USD | 682.12 m USD | 700.81 m USD | 697.05 m USD | 594.46 m USD |
| Cost of revenue | 487.76 m USD | 532.67 m USD | 530.29 m USD | 517.06 m USD | — |
| Gross profit | 151.09 m USD | 149.46 m USD | 170.52 m USD | 179.99 m USD | — |
| Selling, general and administrative expense | 75.34 m USD | 73.35 m USD | 72.61 m USD | 69.96 m USD | 60.6 m USD |
| Operating profit | 4.12 m USD | 1.33 m USD | 39.49 m USD | 17.02 m USD | 6.05 m USD |
| Interest expense | — | — | 13.18 m USD | 11.47 m USD | 12.96 m USD |
| Profit before tax | -6.46 m USD | -5.94 m USD | 40.36 m USD | 10.73 m USD | 5.87 m USD |
| Income tax expense | 13.62 m USD | 12.49 m USD | 10.63 m USD | 4.4 m USD | 3.38 m USD |
| Net income (reported basis) | -20.08 m USD | -18.43 m USD | 29.73 m USD | 6.33 m USD | 2.5 m USD |
| Net income attributable to common shareholders | — | -17.07 m USD | 30.16 m USD | -2.96 m USD | -575 k USD |
| Basic earnings per share | -1.59 USD/share | -1.19 USD/share | 2.02 USD/share | -0.21 USD/share | -0.04 USD/share |
| Diluted earnings per share | -1.59 USD/share | -1.19 USD/share | 2.01 USD/share | -0.21 USD/share | -0.04 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.